About
Werewolf Therapeutics develops conditionally activated immunotherapies that selectively stimulate the immune system within the tumor microenvironment to treat cancer while minimizing off-target effects.
Explore Werewolf Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.